Navigation Links
Codexis Interim Chief Executive Officer to Present at Jefferies Conference
Date:2/21/2012

REDWOOD CITY, Calif., Feb. 21, 2012 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS), a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that Peter Strumph, interim Chief Executive Officer, will be presenting at the Jefferies Global Clean Technology Conference, to be held in New York, NY on Thursday, February 23, 2012 at 1:45 p.m. ET. A live webcast and replay will be available in the Investor section of www.codexis.com.

Codexis, Inc. is a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals and pharmaceutical intermediates.  Codexis' product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol.  Partners and customers include global leaders such as Shell, Merck and Pfizer.  For more information, see www.codexis.com.  

Contacts: 
Investors: Jay Sarwar, ir@codexis.com, 650-421-8126
Media: Wes Bolsen, wes.bolsen@codexis.com, 650-421-8100


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Codexis to Present at the Pacific Crest and Jefferies Conferences
2. Codexis Names Wes Bolsen VP and Chief Marketing Officer
3. Shell Transfers Its Codexis Shares to Raizen
4. Codexis Reports First Quarter 2011 Results
5. Former Senator Byron Dorgan Elected to Codexis Board
6. Codexis Reports Fourth Quarter and Full Year 2010 Results
7. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
8. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
9. Codexis R&D Productivity Panels Also Used By Roche
10. Codexis Names Lori Giver VP Systems Biology
11. Codexis, Teva in Licensing Agreement Final
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
(Date:4/27/2016)... MD (PRWEB) , ... April 27, 2016 , ... ... Greg Lamka, PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors ... plant pathogen detection. , PathSensors deploys the CANARY® test platform for the ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group CEO Benito ... the founder of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received ... cell transplantation for hematologic disorders and the suppression of graft vs. host disease (GVHD) ...
(Date:4/27/2016)... April 27, 2016 MedDay, a biotechnology ... announces the appointment of Catherine Moukheibir as Chairman of its ... Chairman, Jean Jacques Garaud , who contributed to the ... effective immediately. Catherine started her career in strategy ... and London .  She held C-Suite level ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
(Date:3/21/2016)... 2016 Unique technology combines ... superior security   Xura, Inc. ... secure digital communications services, today announced it is working ... enterprise customers, particularly those in the Financial Services Sector, ... authentication within a mobile app, alongside, and in combination ...
(Date:3/14/2016)... , March 14, 2016 NXTD ) ... mobile commerce market, announces the airing of a new series ... the week of March 21 st .  The commercials will ... its popular Squawk on the Street show. --> ... the growing mobile commerce market, announces the airing of a ...
Breaking Biology News(10 mins):